(NASDAQ: SANA) Sana Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.32%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.15%.
Sana Biotechnology's earnings in 2026 is -$211,822,000.On average, 12 Wall Street analysts forecast SANA's earnings for 2026 to be -$186,531,613, with the lowest SANA earnings forecast at -$225,897,537, and the highest SANA earnings forecast at -$160,307,621. On average, 12 Wall Street analysts forecast SANA's earnings for 2027 to be -$180,125,295, with the lowest SANA earnings forecast at -$205,361,397, and the highest SANA earnings forecast at -$141,447,901.
In 2028, SANA is forecast to generate -$189,824,580 in earnings, with the lowest earnings forecast at -$220,030,068 and the highest earnings forecast at -$128,874,754.